chr10-71712781-G-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PP3_Strong
The NM_022124.6(CDH23):āc.3337G>Cā(p.Glu1113Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,460,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000075 ( 0 hom. )
Consequence
CDH23
NM_022124.6 missense
NM_022124.6 missense
Scores
10
5
2
Clinical Significance
Conservation
PhyloP100: 9.96
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM1
In a domain Cadherin 11 (size 105) in uniprot entity CAD23_HUMAN there are 5 pathogenic changes around while only 2 benign (71%) in NM_022124.6
PP3
MetaRNN computational evidence supports a deleterious effect, 0.976
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.3337G>C | p.Glu1113Gln | missense_variant | 28/70 | ENST00000224721.12 | NP_071407.4 | |
C10orf105 | NM_001164375.3 | c.*3155C>G | 3_prime_UTR_variant | 2/2 | ENST00000441508.4 | NP_001157847.1 | ||
CDH23 | NM_001171930.2 | c.3337G>C | p.Glu1113Gln | missense_variant | 28/32 | NP_001165401.1 | ||
C10orf105 | NM_001168390.2 | c.*3155C>G | 3_prime_UTR_variant | 2/2 | NP_001161862.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH23 | ENST00000224721.12 | c.3337G>C | p.Glu1113Gln | missense_variant | 28/70 | 5 | NM_022124.6 | ENSP00000224721 | P1 | |
C10orf105 | ENST00000441508.4 | c.*3155C>G | 3_prime_UTR_variant | 2/2 | 1 | NM_001164375.3 | ENSP00000403151 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245526Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 133680
GnomAD3 exomes
AF:
AC:
3
AN:
245526
Hom.:
AF XY:
AC XY:
3
AN XY:
133680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460606Hom.: 0 Cov.: 31 AF XY: 0.00000964 AC XY: 7AN XY: 726492
GnomAD4 exome
AF:
AC:
11
AN:
1460606
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
726492
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 07, 2013 | The Glu1113Gln variant in CDH23 has been reported in one family with Usher syndr ome type III who also carried a second CDH23 variant and two compound heterozygo us variants in another gene (Le Quesne Stabej 2012). It is unclear if any of the variants identified in this family, including Glu1113Gln, are responsible for t heir clinical features. Computational analyses (biochemical amino acid propertie s, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support f or or against an impact to the protein. Additional data is needed to determine t he clinical significance of this variant. - |
CDH23-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The CDH23 c.3337G>C variant is predicted to result in the amino acid substitution p.Glu1113Gln. This variant was reported in the homozygous state in an individual with autosomal recessive hearing loss (Table S4, Sloan-Heggen et al. 2015. PubMed ID: 26445815) and in a patient with Usher syndrome along with a second CDH23 variant as well as two potentially causative compound heterozygous variants in another gene (Le Quesne Stabej et al. 2011. PubMed ID: 22135276). This variant is reported in 0.0099% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Usher syndrome type 1 Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;D;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;.;H;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
REVEL
Pathogenic
Sift4G
Pathogenic
D;D;.;D;.
Polyphen
0.85
.;.;P;.;.
Vest4
MutPred
Loss of phosphorylation at S1110 (P = 0.1084);Loss of phosphorylation at S1110 (P = 0.1084);Loss of phosphorylation at S1110 (P = 0.1084);Loss of phosphorylation at S1110 (P = 0.1084);Loss of phosphorylation at S1110 (P = 0.1084);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at